Front. Med. Frontiers in Medicine Front. Med. 2296-858X Frontiers Media S.A. 10.3389/fmed.2021.788754 Medicine Systematic Review Combined Effect of Microneedling and Platelet-Rich Plasma for the Treatment of Acne Scars: A Meta-Analysis Kang Cheng Lu Dakai * Department of Otolaryngology-Head and Neck Surgery, HuaMei Hospital, University of Chinese Academy of Sciences, Ningbo, China

Edited by: Robert Gniadecki, University of Alberta, Canada

Reviewed by: Ahmed Mourad, University of Calgary, Canada; Gita Faghihi, Isfahan University of Medical Sciences, Iran

 *Correspondence: Dakai Lu nbludakai_920@21cn.com

This article was submitted to Dermatology, a section of the journal Frontiers in Medicine

 14 02 2022 2021 8 788754 03 10 2021 29 11 2021 Copyright © 2022 Kang and Lu. 2022 Kang and Lu

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 Background

Microneedling is a promising method for the treatment of acne scars, while the effect of microneedling combined with platelet-rich plasma (PRP) remains unknown. We performed a meta-analysis of controlled studies to compare the efficacy and safety of microneedling treatment with and without additional PRP in patients with acne scars.

 Methods

Randomized and non-randomized controlled studies were identified by search of Medline, Embase, and Cochrane's Library databases. Results were pooled with a random-effects model, incorporating the possible heterogeneity.

 Results

Four randomized and 10 split-face non-randomized controlled studies with 472 patients were included. Compared to microneedling therapy without PRP, combined treatment with microneedling and PRP was associated with increased odds of clinical improvement of >50% in Goodman's qualitative scale [GQS: odds ratio (OR): 2.97, 95% confidence interval (CI): 1.96–4.51, p < 0.001; I2 = 0%], and a significantly improved mean GQS score (mean difference: −0.32, 95% CI: −0.44 to −0.20, p < 0.001; I2 = 0%). Combined treatment was associated with a higher patient satisfying rate (OR: 4.15, 95% CI: 2.13 to 8.09, p < 0.001; I2 = 53%), while the incidence of severe adverse events such as severe erythema (OR: 1.59, 95% CI:.73 to 3.46, P = 0.24; I2 = 0%) and severe edema (OR: 1.14, 95% CI: 0.47 to 2.76, P = 0.77; I2 = 0%) were not significantly different.

 Conclusions

Combined treatment with microneedling with PRP is more effective than microneedling without PRP for patients with acne scars.

 acne scar microneedling treatment platelet-rich plasma controlled studies meta-analysis Introduction

Acne vulgaris is a chronic inflammatory disease of skins, which mainly involves the hair follicles and sebaceous glands (1, 2). Acne is common, which could affect up to 80% of the adolescents (3, 4). The most common sequela of acne is acne scars, which could be formed in about 50% of people with acne, most commonly in highly visible areas such as faces and cheeks (5). Atrophic acne scars are the most common type of acne scars, which significantly affect the beauty of the patients and also impair the quality of life for some patients (6, 7). The pathogenesis of atrophic acne scars is complicated, which mainly involves the degradation of inflammatory mediators, collagen fibers, and subcutaneous fat, ultimately leading to the change of subcutaneous collagen deposition (8, 9). Multiple treatment strategies have been developed for the clinical management of acne scars (10, 11). Among them, microneedling is well-applied as an effective and minimally invasive technology for the treatment of atrophic acne scars via creation of skin microwounds to induce collagen production and dermal remodeling (12, 13). Besides, platelet-rich plasma (PRP), which contains various growth factors and bioactive cytokines, has also been applied as adjuvant therapy for acne scars (14, 15). Some small-scale clinical studies have observed the role of combined treatment with microneedling and PRP for patients with atrophic acne scars (16–29). However, the efficacy and safety of microneedling treatment combined with PRP in patients with atrophic acne scars have rarely been comprehensively evaluated. Accordingly, we performed a meta-analysis of controlled studies to systematically compare the efficacy and safety of microneedling treatment with and without additional PRP in patients with acne scars.

 Methods

The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement (30) and the Cochrane Handbook guidelines (31) were followed during the designing and implementation of the study.

Search Strategy

Medline, Embase, and the Cochrane's Library (Cochrane Center Register of Controlled Trials) databases were searched for relevant studies with a combined strategy of: (1) “platelet-rich plasma” OR “PRP” OR “platelet-rich plasma” OR “platelet concentrate” OR “platelet concentrates”; (2) “needle” OR “microneedle” OR “microneedling”; and (3) “scar” OR “scars.” This expanded search strategy was used to avoid missing possible relevant studies. Only clinical studies in humans and published in English were considered. The references of related reviews and original articles were also searched as complementation. The final database search was conducted on June 10, 2021.

 Study Selection

Studies that fulfilled the following criteria were included: (1) articles published as full-length articles in English; (2) designed as split-fact non-randomized controlled studies or parallel-group randomized controlled trials (RCTs); (3) included patients with atrophic acne scars allocated to an interventional group with microneedling and PRP and a control group with microneedling without PRP; and (4) reported at least one of the following outcomes, including the rate of significant clinical improvement defined as >50% improvement in Goodman's qualitative scale (GQS), changes of mean GQS from the baseline, the rate of patient satisfaction, and incidence of severe adverse events. The clinical improvement was assessed by the dermatologists based on GQS. Reviews, studies not including patients with atrophic acne scars, without interventions of microneedling or PRP, without a control group, or studies that did not report the outcomes of interest were excluded.

 Data Extraction and Quality Assessment

Database search, data extraction, and quality evaluation were conducted by two independent authors. If disagreement occurred, it was resolved by consensus between the authors. We extracted data on study information (first author, publication year, and study country), study design (randomized or non-randomized), patient information (number of participants, the range of age, and sex), intervention and control (details of microneedling applied, PRP preparation, and sessions), follow-up duration, and outcomes reported. For RCTs, quality evaluation was achieved using the Cochrane's Risk of Bias Tool (31) according to the following aspects: (1) random sequence generation; (2) allocation concealment; (3) blinding of participants and personnel; (4) blinding of outcome assessors; (5) incomplete outcome data; (6) selective outcome reporting; and (7) other potential bias. For non-randomized studies, quality evaluation was performed with the Newcastle—Ottawa Scale (NOS) (32), which included three domains, such as defining of study groups, between-group comparability, and validation of the outcome. The NOS totally scored from 1 to 9 stars, with 9 stars indicating the highest study quality level.

 Statistical Analysis

Incidence of significant clinical improvement, patient satisfaction, and adverse events were separately evaluated via odds ratios (ORs) and their 95% confidence intervals (CIs) in this meta-analysis, while changes of mean GQS from the baseline were evaluated with mean difference (MD) and corresponding 95% CI. We used Cochrane's Q test to detect the heterogeneity (33). The I2 statistic was also calculated, and an I2 > 50% reflected significant heterogeneity. Pooled analyses were calculated using a random-effects model because this method incorporates the influence of potential heterogeneity and retrieves a more generalized result (31). Sensitivity analysis was performed to compare the treatments between microneedling and PRP with microneedling alone (31). Predefined subgroup analyses were used to evaluate the possible influences of study design on the outcomes. Publication bias was evaluated by visual inspection of funnel plots, and Egger's regression asymmetry test (34). P < 0.05 were considered statistically significant. The RevMan (Version 5.1; Cochrane, Oxford, UK) and Stata software (Version 12.0; Stata, College Station, TX) were applied for statistical analyses.

 Results Search Results

The process of database search and study identification is shown in Figure 1. Briefly, 532 articles were obtained through the database search, and 409 were retrieved after exclusion of duplicated records. Among them, 374 articles were subsequently excluded based on titles and abstracts, primarily because these studies were irrelevant to the aim of the meta-analysis. Of the 35 articles that underwent full-text review, 21 were further excluded for the reasons presented in Figure 1. Finally, 14 studies, including four RCTs (19, 22–24) and 10 non-randomized controlled studies (16–18, 20, 21, 25–29) were included.

A flow chart of literature search. From Moher et al. (35).

 Study Characteristics

Table 1 shows the characteristics of the included studies. Overall, four RCTs (19, 22–24) and 10 face-split non-randomized controlled studies (16–18, 20, 21, 25–29) with 472 patients were included in the meta-analysis. The studies were published between 2011 and 2021. The studies were mostly performed in India (17, 18, 22, 23, 26–29) and Egypt (19–21, 24, 25), as well as one study in Italy (16). All of the studies included patients with acne scars. The mean ages varied between 23 and 33 years, and the proportions of men ranged between 25 and 70%. The details of PRP preparation are also summarized in Table 1, which typically included two steps of centrifugation of the autologous whole blood, except for one study (27), which applied a one-step centrifugation method. For the comparisons, interventions of combined microneedling and PRP were compared with controls of microneedling alone in nine studies (16, 19–24, 26, 27), with microneedling and distilled water or normal saline in two studies (18, 29), and with microneedling and vitamin C, hyaluronic acid, and insulin in the other three studies (17, 25, 28). For each treatment, two to six sessions were applied, with the follow-up durations varying from 4 to 32 weeks.

Characteristics of the included studies.

References Country Design No. of patients Scar characteristics Age (years) Male (%) Details of MN PRP preparation Intervention Control Sessions Follow-up duration (weeks) Outcome assessment
Fabbrocini et al. (16) Italy NRCT, Split-face study 12 Acne scars 32.2 41.7 Using rolling barrel 1-mm wide, equipped with 96 needles in 4 rows 70–80 ml autologous whole blood centrifuged at 1,200 g for 15 min, then further centrifuged at 1,800 g for 10 min, to get a 4.5 × PRP MN + PRP MN only 2 32 Rate of GQS improvement and changes of GQS
Chawla (17) India NRCT, Split-face study 27 Grade 2–4 acne scars 27.5 70 Using rolling drum of 192 needles 10 ml autologous whole blood centrifuged at 1500 rpm for 10 min, then further centrifuged at 3700 rpm for 10 min, to get a 4.5x PRP MN + PRP MN + Vitamin C 3 4 Rate of GQS improvement and patient satisfying
Asif et al. (18) India NRCT, Split-face study 50 Grade 2–4 acne scars 25.7 50 Using a standard roller device with 192 needles, each of 1.5 mm in size 17 ml autologous whole blood centrifuged at 294 g for 5 min, then further centrifuged at 691 g for 17 min, to get a 5.2 × PRP MN + PRP MN + distilled water 3 12 Rate of GQS improvement and patient satisfying
Ibrahim et al. (19) Egypt RCT, OL 36 Acne scars 26.3 49 Using an automated microneedling device (dermapen 3) with nine microneedles of 0.25 mm to 2.5 mm length 20 ml autologous whole blood centrifuged at 1,419 g for 7 min, then further centrifuged at 2,522 g for 5 min, to get a 10 × PRP MN + PRP MN only 6 12 Rate of GQS improvement and incidence of severe side effect
Porwal et al. (22) India RCT, OL 55 Grade 2–4 acne scars 26 46.2 Using a dermaroller with 192 needles of 1.5 mm length 20 ml autologous whole blood centrifuged at 1,200 rpm for 15 min, then further centrifuged at 2,000 rpm for 10 min, to get a PRP MN + PRP MN only 3 4 Changes of GQS and incidence of severe side effect
El-Domyati et al. (20) Egypt NRCT, Split-face study 24 Acne scars 27.3 25 Using a dermaroller with 600 needles of 1.5 mm length 10 ml autologous whole blood centrifuged at 252 g for 10 min, then further centrifuged at 1,792 g for 5 min, to get a PRP MN + PRP MN only 2 12 Rate of GQS improvement
Ibrahim et al. (21) Egypt NRCT, Split-face study 35 Acne scars 24.7 NR Using a dermaroller with 192 needles of 1.5 mm length 10 ml autologous whole blood centrifuged at 2,500 rpm for 10 min, then further centrifuged at 3,500 rpm for 10 min, to get a PRP MN + PRP MN only 4 12 Changes of GQS and rate of patient satisfying
Bhargava et al. (23) India RCT, SB 30 Grade 4 acne scars 27.7 36.7 Using a dermaroller with 192 needles of 1.5 mm length 10 ml autologous whole blood centrifuged at 1,500 rpm for 10 min, then further centrifuged at 3,700 rpm for 10 min, to get a 4.5 × PRP MN + PRP MN only 3 12 Rate of GQS improvement and patient satisfying
Elfar and Hasby (24) Egypt RCT, SB 40 Grade 2–4 acne scars 27.2 30 Using a dermaroller with 540 needles of 2.0 mm length 10 ml autologous whole blood centrifuged at 72 g for 15 min, then further centrifuged at 1,006 g for 5 min, to get a PRP MN + PRP MN only 4 12 Rate of GQS improvement
Sharma et al. (29) India NRCT, Split-face study 40 Grade 2–4 acne scars 25.3 32.5 Using a dermaroller with 192 needles of 1.5 mm length 10 ml autologous whole blood centrifuged at 1,500 rpm for 10 min, then further centrifuged at 3,700 rpm for 10 min, to get a 4.5 × PRP MN + PRP MN + NS 4 24 Rate of GQS improvement, changes of GQS, and incidence of severe side effect
Amer et al. (25) Egypt NRCT, Split-face study 41 Grade 2–4 acne scars 28 31.7 Using a dermaroller 10 ml autologous whole blood centrifuged at 1,600 rpm for 10 min, then further centrifuged at 4,000 rpm for 15 min, to get a PRP MN + PRP MN + HA 4 4 Rate of GQS improvement and patient satisfying
Pawar and Singh (28) India NRCT, Split-face study 16 Acne scars 24.7 43.8 Using a dermaroller with 192 needles of 1.5 mm length 10 ml autologous whole blood centrifuged at 1,500 rpm for 10 min, then further centrifuged at 3,700 rpm for 10 min, to get a 4.5 × PRP MN + PRP MN + insulin 4 12 Changes of GQS and incidence of severe side effect
Gupta et al. (26) India NRCT, Split-face study 36 Acne scars 23.7 47.2 Using a dermaroller with 192 needles of 2.0 mm length 8.5 ml autologous whole blood centrifuged at 1,400 rpm for 10 min, then further centrifuged at 3,500 rpm for 10 min, to get a PRP MN + PRP MN only 4 24 Changes of GQS
Nandini et al. (27) India NRCT, Split-face study 30 Grade 2–4 acne scars 25 60 Using a dermaroller with 192 needles of 2.0 mm length 6 ml autologous whole blood centrifuged at 3,600 rpm for 15 min to get a PRP MN + PRP MN only 4 12 Rate of GQS improvement and patient satisfying

MN, microneedling; PRP, platelet-rich plasma; NRCT, nonrandomized controlled trials; RCT, randomized controlled trials; OL, open-label; SB, single-blind; HA, hyaluronic acid; GQS, Goodman's qualitative scale; NR, not reported; NS, normal saline.

 Data Quality

Table 2 shows the details of the study quality of the included non-randomized studies (16–18, 20, 21, 25–29). The NOS varied between 8 and 9 stars, indicating generally good study quality. Table 3 shows the details of study quality of the included RCTs (19, 22–24). Two of the RCTs were open-label (19, 22), and the other two were single-blinded (23, 24). The method of random sequence generation and information of allocation concealment was reported in only one RCT (24). The overall quality score varied between 3 and 7, indicating moderate to good study quality.

Quality evaluation via the Newcastle—Ottawa Scale for non-randomized controlled studies.

References Representativeness of the exposed cohort Selection of the non-exposed cohort Ascertainment of exposure Demonstration that outcome of interest was not present at start of study Comparability-age and gender Comparability-other factors Assessment of outcome Was follow-up long enough for outcomes to occur Adequacy of follow-up of cohorts Total
Fabbrocini et al. (16) 1 1 1 1 1 1 1 1 1 9
Chawla (17) 1 1 1 1 1 1 1 1 0 8
Asif et al. (18) 1 1 1 1 1 1 1 1 1 9
El-Domyati et al. (20) 1 1 1 1 1 1 1 1 0 8
Ibrahim et al. (21) 1 1 1 1 1 1 1 1 1 9
Sharma et al. (29) 1 1 1 1 1 1 1 1 1 9
Amer et al. (25) 1 1 1 1 1 1 1 1 1 9
Pawar and Singh (28) 1 1 1 1 1 1 1 1 0 8
Gupta et al. (26) 1 1 1 1 1 1 1 1 0 8
Nandini et al. (27) 1 1 1 1 1 1 1 1 1 9

Quality evaluation for the randomized controlled trials via the Cochrane's Risk of Bias Tool.

References Random sequence generation Allocation concealment Blinding of participants Blinding of outcome assessment Incomplete outcome data addressed Selective reporting Other sources of bias Total
Ibrahim et al. (19) Unclear Unclear High High Low Low Low 3
Porwal et al. (22) Unclear Unclear High High Low Low Low 3
Bhargava et al. (23) Unclear Unclear High Low Low Low Low 4
Elfar and Hasby (24) Low Low High Low Low Low Low 6
Meta-Analysis Results

Pooled results of 10 studies (16–20, 23–25, 27, 29) showed that combined treatment with microneedling and PRP was associated with increased odds of significant clinical improvement as compared with microneedling therapy without PRP (OR: 2.97, 95% CI: 1.96 to 4.51, p < 0.001; Figure 2A) without significant heterogeneity (P for Cochrane's Q-test = 0.45, I2 = 0%). Sensitivity analysis showed consistent results limited to the comparisons between the combined treatment and microneedling alone (OR: 4.58, 95% CI: 2.49 to 8.42, p < 0.001; I2 = 0%). Subgroup analyses according to the study design showed both significant results in non-randomized studies and RCTs, while the effect was more remarkable in RCTs than in non-randomized studies (OR: 7.85 vs. 3.02, P for subgroup difference = 0.02; Figure 2A). In addition, combined treatment with microneedling and PRP was associated with a significantly improved mean GQS score (six studies MD: −0.32, 95% CI: −0.44 to −0.20, p < 0.001; I2 = 0%; Figure 2B) and a higher patient satisfying rate (six studies, OR: 4.15, 95% CI: 2.13 to 8.09, p < 0.001; I2 = 53%; Figure 2C) compared to treatment with microneedling without PRP. Subgroup analyses showed that difference in study design did not significantly affect the results (P for subgroup difference = 0.22 and 0.63, respectively). Meta-analyses of three and two studies showed that the incidence of severe adverse events such as severe erythema (OR: 1.59, 95% CI: 0.73 to 3.46, P = 0.24; I2 = 0%; Figure 3A) and severe edema (OR: 1.14, 95% CI: 0.47 to 2.76, P = 0.77; I2 = 0%; Figure 3B) were not significantly different between the two treatment groups.

Forest plots for the meta-analyses, comparing the effect of combined treatment with microneedling and PRP vs. microneedling without PRP for patients with acne scars; (A) the rate of significant clinical improvement; (B) difference of changes of GQS after treatment; and (C) the rate of patient satisfaction.

Forest plots for the meta-analyses, comparing the safety of combined treatment with microneedling and PRP vs. microneedling without PRP for patients with acne scars; (A) incidence of severe erythema; and (B) incidence of severe edema.

 Publication Bias

The funnel plots for the meta-analyses of outcomes of the significant clinical improvement rate, changes of GQS, and the patient satisfying rate are shown in Figures 4A–C, respectively. These plots were symmetrical, suggesting low risk of publication biases among the outcomes. Egger's regression tests also showed low risks of publication biases for these meta-analyses (P for Egger's regression test = 0.534, 0.328, and 0.297, respectively).

Funnel plots for the publication bias within the meta-analyses, comparing the effect of combined treatment with microneedling and PRP vs. microneedling without PRP for patients with acne scars; (A) funnel plots for the rate of significant clinical improvement; (B) funnel plots for the difference of changes of GQS after treatment; and (C) funnel plots for the rate of patient satisfaction.

 Discussion

In this meta-analysis, by pooling the results of 14 non-randomized studies and RCTs, we found that a combined treatment with microneedling and PRP was associated with better improvement of atrophic acne scars than microneedling without PRP. The efficacy of a combined treatment was evidenced by the higher rate of significant improvement and better improved GQS evaluated by dermatologists and the higher satisfying rate from the patients. Besides, pooled results of limited datasets suggested no significant difference in the incidence of severe adverse events between groups, such as severe erythema and edema. Taken together, the results of our meta-analysis indicated that combined treatment with microneedling with PRP is more effective than microneedling without PRP for patients with acne scars, without further increasing the risk of adverse events. These findings support PRP as an adjuvant therapy for patients with acne scars receiving microneedling therapy.

To the best of our knowledge, few meta-analyses were performed to evaluate the efficacy and safety of additional PRP as an adjuvant therapy for patients with acne scars receiving microneedling therapy. A previous meta-analysis, including five comparative studies before 2019 with 226 patients with atrophic scars showed that a combined treatment with microneedling and PRP may confer better efficacy in patients with atrophic acne scars than treatment with microneedling alone. However, the results were based on limited studies, and other efficacy outcomes, such as changes of GQS, were unable to be determined (36). Our study has several strengths compared to the previous one (36). Firstly, an up-to-date and compressive literature search was performed. With the expanded literature search strategy, we identified 14 comparative studies, including 472 patients, which were much larger than the previous one. Moreover, the relatively larger number of studies enables us to evaluate the efficacy of a combined therapy with microneedling and PRP in a multidimensional manner, including the outcomes of the significant clinical improvement rate, between-group difference of GQS changes, and the patient satisfying rate. All of these outcomes consistently indicated a better efficacy of the combined therapy with PRP compared to microneedling without PRP for acne scars. In addition, safety outcomes were also explored, which did not show that additional use of PRP was associated with an increased risk of severe adverse events. Finally, sensitivity analysis and subgroup analysis according to the design of the studies were performed, and the consistent results further assured the stability of the findings.

The possible synergistic effect of PRP on the basis of microneedling treatment for atrophic acne scars may be explained by multiple mechanisms (37). The primary mechanisms for the microneedling treatment are the formation of skin microwounds to induce collagen production and dermal remodeling (12, 13). Previous studies have confirmed that PRP contains multiple active cytokines and growth factors that are primarily released from the a-granules of platelets and actively involved in the process of dermal remodeling, such as the dermal-transforming growth factor, the platelet-derived growth factor, the vascular endothelial growth factor, and the fibroblast growth factor (38, 39). The skin microwounds resulting from the microneedling therapy may also enhance the absorption of the above active cytokines in PRP by the skin (12, 13). However, studies evaluating the mechanisms underlying the synergetic therapeutic efficacy of microneedling and PRP are limited. Interestingly, a recent study has shown that, compared to the use of microneedling alone, combined treatment with microneedling and PRP was associated with a marked excellent improvement of the skin lesions, a more significant deposition of collagen and elastic fibers, and an increased proliferative activity in the epidermis in people with striae distensa, which may also reflect the synergetic benefits of action microneedling and PRP on scar formation and collagen/dermal remodeling (40). Interestingly, the efficacy of combined treatment with microneedling and PRP has also been observed in people with androgenetic alopecia (41) and melisma (42). The exact molecular mechanisms underlying the benefits of a combined therapy with microneedling and PRP for atrophic acne scars should be further evaluated.

Some limitations of the current meta-analysis should be considered when the results are interpreted. Firstly, the numbers of available studies and the included patients for some outcomes were limited. For example, meta-analysis of adverse events only involved 2–3 studies; the results of which should be validated in large-scale RCTs. In addition, the limited number of available datasets may also reduce the reliability of funnel plots for the estimation of publication biases. In particular, it has been suggested that visual interpretation of funnel plots is too subjective to be useful (31), and it has been pointed out that the researchers had only a limited ability to identify correctly funnel plots for meta-analyses that were subject to bias due to missing results (43). Moreover, quality scores of the included RCTs were moderate, and 10/14 of the included studies were non-randomized face-split studies, although subgroup analysis according to study design was performed. Accordingly, high-quality large-scale RCTs with adequate statistical power are warranted to verify our findings. In addition, the optimal PRP formulation remains unknown, and the influence of PRP formulation on the outcomes was not performed because most of the included studies did not provide adequate details related with PRP preparation. Finally, most of the studies were performed in India and Egypt. Studies from the other regions of the world are warranted to validate the findings.

In conclusion, the results of our meta-analysis indicated that combined treatment with microneedling with PRP is more effective than microneedling without PRP for patients with acne scars, without further increasing the risk of adverse events. Although large-scale RCTs are warranted to confirm these results, the findings of the meta-analysis support using PRP as an adjuvant therapy for patients with acne scars receiving microneedling therapy.

 Data Availability Statement

The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author/s.

 Author Contributions

CK and DL designed the study, performed database search, data extraction, statistical analyses, and interpretation of the results. CK drafted the manuscript. DL critically revised the manuscript. All authors approved the submission of the manuscript.

 Funding

This study was supported by HwaMei Research Foundation of HwaMei Hospital and University of Chinese Academy of Sciences (No. 2022HMZD10).

 Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

 Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

 References Zaenglein AL Pathy AL Schlosser BJ Alikhan A Baldwin HE Berson DS . Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. (2016) 74:945–73.e933. 10.1016/j.jaad.2015.12.03726897386 Berry K Lim J Zaenglein AL. Acne vulgaris: treatment made easy for the primary care physician. Pediatr Ann. (2020) 49:e109–15. 10.3928/19382359-20200211-0132155276 Tan JK Bhate K. A global perspective on the epidemiology of acne. Br J Dermatol. (2015) 172(Suppl 1):3–12. 10.1111/bjd.1346225597339 Layton AM Thiboutot D Tan J. Reviewing the global burden of acne: how could we improve care to reduce the burden? Br J Dermatol. (2021) 184:219–25. 10.1111/bjd.1947732770673 Boen M Jacob C. A review and update of treatment options using the acne scar classification system. Dermatol Surg. (2019) 45:411–22. 10.1097/DSS.000000000000176530856634 Gieler U Gieler T Kupfer JP. Acne and quality of life - impact and management. J Eur Acad Dermatol Venereol. (2015) 29(Suppl 4):12–4. 10.1111/jdv.1319126059729 Dreno B Amici JM Demessant-Flavigny AL Wright C Taieb C Desai SR . The impact of acne, atopic dermatitis, skin toxicities and scars on quality of life and the importance of a holistic treatment approach. Clin Cosmet Investig Dermatol. (2021) 14:623–32. 10.2147/CCID.S31584634163201 Connolly D Vu HL Mariwalla K Saedi N. Acne scarring-pathogenesis, evaluation, and treatment options. J Clin Aesthet Dermatol. (2017) 10:12–23.29344322 Tan J Thiboutot D Gollnick H Kang S Layton A Leyden JJ . Development of an atrophic acne scar risk assessment tool. J Eur Acad Dermatol Venereol. (2017) 31:1547–54. 10.1111/jdv.1432528499079 Zaleski-Larsen LA Fabi SG Mcgraw T Taylor M. Acne scar treatment: a multimodality approach tailored to scar type. Dermatol Surg. (2016) 42(Suppl 2):S139–49. 10.1097/DSS.000000000000074627128240 Bhargava S Cunha PR Lee J Kroumpouzos G. Acne scarring management: systematic review and evaluation of the evidence. Am J Clin Dermatol. (2018) 19:459–77. 10.1007/s40257-018-0358-529744784 Juhasz MLW Cohen JL. Microneedling for the treatment of scars: an update for clinicians. Clin Cosmet Investig Dermatol. (2020) 13:997–1003. 10.2147/CCID.S26719233376377 Schoenberg E O'connor M Wang JV Yang S Saedi N. Microneedling and PRP for acne scars: a new tool in our arsenal. J Cosmet Dermatol. (2020) 19:112–4. 10.1111/jocd.1298831070298 Zhang M Park G Zhou B Luo D. Applications and efficacy of platelet-rich plasma in dermatology: a clinical review. J Cosmet Dermatol. (2018) 17:660–5. 10.1111/jocd.1267330047234 Hesseler MJ Shyam N. Platelet-rich plasma and its utility in medical dermatology: a systematic review. J Am Acad Dermatol. (2019) 81:834–46. 10.1016/j.jaad.2019.04.03731009668 Fabbrocini G De Vita V Pastore F Panariello L Fardella N Sepulveres R . Combined use of skin needling and platelet-rich plasma in acne scarring treatment. Cosmetic Dermatol. (2011) 24:177–83. Chawla S. Split face comparative study of microneedling with PRP versus microneedling with vitamin c in treating atrophic post acne scars. J Cutan Aesthet Surg. (2014) 7:209–12. 10.4103/0974-2077.15074225949034 Asif M Kanodia S Singh K. Combined autologous platelet-rich plasma with microneedling verses microneedling with distilled water in the treatment of atrophic acne scars: a concurrent split-face study. J Cosmet Dermatol. (2016) 15:434–43. 10.1111/jocd.1220726748836 Ibrahim ZA El-Ashmawy AA Shora OA. Therapeutic effect of microneedling and autologous platelet-rich plasma in the treatment of atrophic scars: a randomized study. J Cosmet Dermatol. (2017) 16:388–99. 10.1111/jocd.1235628504480 El-Domyati M Abdel-Wahab H Hossam A. Microneedling combined with platelet-rich plasma or trichloroacetic acid peeling for management of acne scarring: a split-face clinical and histologic comparison. J Cosmet Dermatol. (2018) 17:73–83. 10.1111/jocd.1245929226630 Ibrahim MK Ibrahim SM Salem AM. Skin microneedling plus platelet-rich plasma versus skin microneedling alone in the treatment of atrophic post acne scars: a split face comparative study. J Dermatolog Treat. (2018) 29:281–6. 10.1080/09546634.2017.136511128782384 Porwal S Chahar YS Singh PK. A Comparative study of combined dermaroller and platelet-rich plasma versus dermaroller alone in acne scars and assessment of quality of life before and after treatment. Indian J Dermatol. (2018) 63:403–8. 10.4103/ijd.IJD_118_1730210162 Bhargava S Kroumpouzos G Varma K Kumar U. Combination therapy using subcision, needling, and platelet-rich plasma in the management of grade 4 atrophic acne scars: a pilot study. J Cosmet Dermatol. (2019) 18:1092–7. 10.1111/jocd.1293530924301 Elfar NN Hasby EA. Efficacy and safety of plasma gel as a new modality in treatment of atrophic acne scars. Int J Dermatol. (2020) 59:620–6. 10.1111/ijd.1481532108322 Amer A Elhariry S Al-Balat W. Combined autologous platelet-rich plasma with microneedling versus microneedling with non-cross-linked hyaluronic acid in the treatment of atrophic acne scars: Split-face study. Dermatol Ther. (2021) 34:e14457. 10.1111/dth.1445733107665 Gupta M Barman KD Sarkar R. A comparative study of microneedling alone versus along with platelet-rich plasma in acne scars. J Cutan Aesthet Surg. (2021) 14:64–71.34084010 Nandini AS Sankey SM Sowmya CS Sharath Kumar BC. Split-face comparative study of efficacy of platelet-rich plasma combined with microneedling versus microneedling alone in treatment of post-acne scars. J Cutan Aesthet Surg. (2021) 14:26–31. 10.4103/JCAS.JCAS_160_1834084005 Pawar M Singh M. Microneedling with autologous platelet-rich plasma versus microneedling with topical insulin in the treatment of postacne atrophic scars: a simultaneous split-face comparative study. J Am Acad Dermatol. (2021) 84:810–1. 10.1016/j.jaad.2020.05.15234403715 Sharma S Kaur T Bassi R. A split face comparative study to evaluate the efficacy of skin microneedling and platelet rich plasma (PRP) combination versus skin microneedling alone for treatment of post acne scars. J Pakistan Assoc Dermatol. (2021) 30:449–55. Moher D Liberati A Tetzlaff J Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. (2009) 339:b2535. 10.1136/bmj.b253520171303 Higgins J. Green S. (2011). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration. Available online at: www.cochranehandbook.org (accessed August 20, 2021). Wells GA Shea B O'connell D Peterson J Welch V Losos M. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. (2010). Available online at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed August 20, 2021). Higgins JP Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. (2002) 21:1539–58. 10.1002/sim.118612111919 Egger M Davey Smith G Schneider M Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. (1997) 315:629–34. 10.1136/bmj.315.7109.6299310563 Moher D Liberati A Tetzlaff J Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. (2009) 6:e1000097. 10.1371/journal.pmed100009720171303 Chang HC Sung CW Lin MH. Combination therapy with microneedling and platelet-rich plasma for acne scarring: a systematic review and meta-analysis. Dermatol Surg. (2020) 46:1118–22. 10.1097/DSS.000000000000203331453904 Hashim PW Levy Z Cohen JL Goldenberg G. Microneedling therapy with and without platelet-rich plasma. Cutis. (2017) 99:239–42. Mussano F Genova T Munaron L Petrillo S Erovigni F Carossa S. Cytokine, chemokine, and growth factor profile of platelet-rich plasma. Platelets. (2016) 27:467–71. 10.3109/09537104.2016.114392226950533 Samadi P Sheykhhasan M Khoshinani HM. The use of platelet-rich plasma in aesthetic and regenerative medicine: a comprehensive review. Aesthetic Plast Surg. (2019) 43:803–14. 10.1007/s00266-018-1293-930552470 Abdel-Motaleb AA Zedan H Mostafa MM Abu-Dief EE Gebril SM Abdelwahed Hussein MR. Combined microneedling with topical application of platelet-rich plasma versus microneedling alone in the treatment of stria distensae: clinicopathological analysis. J Dermatolog Treat. (2020) 31:1–12. 10.1080/09546634.2020.178232332538219 Strazzulla LC Avila L Lo Sicco K Shapiro J. An Overview of the Biology of Platelet-Rich Plasma and Microneedling as Potential Treatments for Alopecia Areata. J Investig Dermatol Symp Proc. (2018) 19:S21–4. 10.1016/j.jisp.2017.10.00229273100 Zhao L Hu M Xiao Q Zhou R Li Y Xiong L . Efficacy and safety of platelet-rich plasma in melasma: a systematic review and meta-analysis. Dermatol Ther. (2021) 11:1587–97. 10.1007/s13555-021-00575-z34269967 Terrin N Schmid CH Lau J. In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias. J Clin Epidemiol. (2005) 58:894–901. 10.1016/j.jclinepi.2005.01.00616085192